GlassScriptPhysician profile
Ashley L Peterman Barron
NPI 1609374321
$729.60
in general payments reported to CMS, 2019-2025
18 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $171 · 2024: $168 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $129.53 | 2021-2022 | |
| Hologic Sales and Service, LLC | $105.10 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $79.67 | 2021-2022 | |
| Axsome Therapeutics, INC. | $70.14 | 2024-2025 | Auvelity |
| Amgen INC. | $45.30 | 2021-2024 | Tavneos, Parsabiv, Aranesp |
| Millicent US INC | $41.39 | 2025 | Intrarosa, Femlyv |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $30.67 | 2025 | Rexulti |
| Novo Nordisk INC | $30.30 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Organon LLC | $28.39 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $28.25 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $25.03 | 2024 | Spravato |
| Tactile Systems Technology INC | $22.82 | 2025 | Flexitouch Plus, Nimbl |
| Exact Sciences Corporation | $17.98 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $17.86 | 2025 | Mounjaro |
| Becton, Dickinson and Company | $16.15 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $14.01 | 2021 | |
| Abbvie INC. | $13.75 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Peterman Barron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.